These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 12042802)

  • 21. Divergent evolution of hemagglutinin and neuraminidase genes in recent influenza A:H3N2 viruses isolated in Canada.
    Abed Y; Hardy I; Li Y; Boivin G
    J Med Virol; 2002 Aug; 67(4):589-95. PubMed ID: 12116009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Divergent genetic evolution of hemagglutinin in influenza A H1N1 and A H1N2 subtypes isolated in the south-France since the winter of 2001-2002.
    Al Faress S; Cartet G; Ferraris O; Norder H; Valette M; Lina B
    J Clin Virol; 2005 Jul; 33(3):230-6. PubMed ID: 15911445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic and antigenic relatedness of H3 subtype influenza A viruses isolated from avian and mammalian species.
    Yassine HM; Lee CW; Suarez DL; Saif YM
    Vaccine; 2008 Feb; 26(7):966-77. PubMed ID: 18206275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccines. Shifting tactics in the battle against influenza.
    Ault A
    Science; 2004 Feb; 303(5662):1280. PubMed ID: 14988531
    [No Abstract]   [Full Text] [Related]  

  • 25. Thinking about broadly cross-reactive vaccines.
    Doherty PC; Turner SJ
    Clin Pharmacol Ther; 2009 Jun; 85(6):665-8. PubMed ID: 19404249
    [No Abstract]   [Full Text] [Related]  

  • 26. From lethal virus to life-saving vaccine: developing inactivated vaccines for pandemic influenza.
    Wood JM; Robertson JS
    Nat Rev Microbiol; 2004 Oct; 2(10):842-7. PubMed ID: 15378048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human infection by a swine influenza A (H1N1) virus in Switzerland.
    Gregory V; Bennett M; Thomas Y; Kaiser L; Wunderli W; Matter H; Hay A; Lin YP
    Arch Virol; 2003 Apr; 148(4):793-802. PubMed ID: 12664301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunogenicity and tolerability of inactivated flu vaccine in high risk and healthy children.
    Avila Aguero ML; Soriano-Fallas A; Umaña-Sauma MA; Ulloa-Gutierrez R; Arnoux S
    Medicina (B Aires); 2007; 67(4):351-9. PubMed ID: 17891930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influenza DNA vaccine: an update.
    Chen Z
    Chin Med J (Engl); 2004 Jan; 117(1):125-32. PubMed ID: 14733788
    [No Abstract]   [Full Text] [Related]  

  • 30. Increased adamantane resistance in influenza A(H3) viruses in Australia and neighbouring countries in 2005.
    Barr IG; Hurt AC; Iannello P; Tomasov C; Deed N; Komadina N
    Antiviral Res; 2007 Feb; 73(2):112-7. PubMed ID: 16963130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetically destined potentials for N-linked glycosylation of influenza virus hemagglutinin.
    Igarashi M; Ito K; Kida H; Takada A
    Virology; 2008 Jul; 376(2):323-9. PubMed ID: 18456302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of vaccine strains of H5 and H7 influenza viruses.
    Soda K; Sakoda Y; Isoda N; Kajihara M; Haraguchi Y; Shibuya H; Yoshida H; Sasaki T; Sakamoto R; Saijo K; Hagiwara J; Kida H
    Jpn J Vet Res; 2008 Jan; 55(2-3):93-8. PubMed ID: 18318111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase.
    Pavlova SP; Veits J; Keil GM; Mettenleiter TC; Fuchs W
    Vaccine; 2009 Jan; 27(5):773-85. PubMed ID: 19041677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Application of gene sequence cluster in research for H3 antigenic evolution of influenza A virus].
    Zhang WT; Jiang QW; Jiang LF; Ju LW
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Dec; 25(12):1046-9. PubMed ID: 15769361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new approach to an influenza life vaccine: haemagglutinin cleavage site mutants generated by reverse genetics.
    Stech J; Klenk HD
    Berl Munch Tierarztl Wochenschr; 2006; 119(3-4):186-91. PubMed ID: 16573209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of 2 influenza A(H3N2) clinical isolates with reduced susceptibility to neuraminidase inhibitors due to mutations in the hemagglutinin gene.
    Abed Y; Bourgault AM; Fenton RJ; Morley PJ; Gower D; Owens IJ; Tisdale M; Boivin G
    J Infect Dis; 2002 Oct; 186(8):1074-80. PubMed ID: 12355356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparison of characterization of hemagglutination and HA1 sequence of currently circulating strains of influenza A (H3N2) virus in Zhejiang province and in Japan].
    Lu YY; Yan JY; Zhou M; Jiang XL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Jan; 24(1):15-8. PubMed ID: 12678955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influenza vaccines: the virosome concept.
    Wilschut J
    Immunol Lett; 2009 Feb; 122(2):118-21. PubMed ID: 19100779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Picture story. Fight the flu.
    Nat Struct Biol; 1998 Dec; 5(12):1032. PubMed ID: 9846870
    [No Abstract]   [Full Text] [Related]  

  • 40. Perspectives on the characteristics and achievements of recent surveillance of influenza activity in Japan.
    Nerome R; Nerome K; Tanabe N; Lindstrom SE; Shinjo M; Taniguchi S; Kasai K
    Vaccine; 2002 May; 20 Suppl 2():S36-43. PubMed ID: 12110254
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.